newsfilter
← Latest News
GlobeNewswire·

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

PCRX
  • Pacira BioSciences released findings from the Standing Strong survey of 1,000 U.S. adults in physically demanding roles, conducted between April 17 & May 3, 2026.
  • 85% of respondents reported experiencing orthopedic pain at work, with 41% stating they often or always experience pain.
  • Knee pain is the most common complaint, affecting nearly 75% of workers with pain, while 56% report chronic knee pain persisting for three months or longer.
  • 54% of workers lost income due to pain-related missed shifts or reduced hours, & 46% said pain prevented career advancement opportunities.
  • 55% of respondents would choose a less physically demanding career if possible, rising to 73% among active military personnel.
  • 81% of workers managed pain without informing supervisors, & nearly 90% typically push through pain rather than seeking help.
  • 66% of those with primary knee pain reported negative effects on their social lives & personal relationships.
  • While 24% of workers with chronic knee pain use prescription opioids, 98% expressed interest in long-lasting, non-opioid treatment options.
  • Dr. Anthony Boniello highlighted ZILRETTA (triamcinolone acetonide extended-release injectable suspension) as a non-opioid option for managing osteoarthritis knee pain.
  • Pacira BioSciences promotes non-opioid therapies including EXPAREL, ZILRETTA, & iovera to improve mobility & function for patients.
  • ZILRETTA is indicated for osteoarthritis knee pain, with potential side effects including infection, joint damage, & hormonal changes.
  • The survey is not representative of all U.S. workers & reflects only the experiences of full-time employees working on their feet.